Veterans Affairs

Composition and methods for the prevention and treatment of diet-induced obesity

  • US Patent No. 10107795
  • Issued: October 23, 2018
  • Status: Active
Medical & Biotechnology

Blunting the activity of the P2Y2 receptor results in a resistance to diet-induced obesity, an increased metabolic rate, and a better glucose tolerance. Compounds that inhibit the puringeric P2Y2 receptor are useful for treating disorders associated with diabetes, treating obesity, and increasing metabolism (e.g., fatty acid metabolism).

Do you have questions or need more information on a specific technology? Let's talk.

Contact Us